Literature DB >> 10762418

Conference highlight: do T cells care about the mitogen-activated protein kinase signalling pathways?

M Rincón1, D Conze, L Weiss, N L Diehl, K A Fortner, D Yang, R A Flavell, H Enslen, A Whitmarsh, R J Davis.   

Abstract

Mitogen-activated protein (MAP) kinases, which include the extracellular response kinases, p38 and c-Jun amino terminal kinases (JNK), play a significant role in mediating signals triggered by cytokines, growth factors and environmental stress. The JNK and p38 MAP kinases have been involved in growth, differentiation and cell death in different cell types. In the present paper, we describe how the JNK and p38 MAP kinase signalling pathways are regulated and their role during thymocyte development and the activation and differentiation of T cells in the peripheral immune system. The results from these studies demonstrate that the JNK and p38 MAP kinase signalling pathways regulate different aspects of T-cell mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762418     DOI: 10.1046/j.1440-1711.2000.00900.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  4 in total

1.  Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells.

Authors:  Melissa D Lajevic; Samia Suleiman; Rhonna L Cohen; Donald A Chambers
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection.

Authors:  Hong-Yi Chen; Mei-Hui Lin; Chien-Cheng Chen; Jwu-Ching Shu
Journal:  BMC Microbiol       Date:  2017-04-13       Impact factor: 3.605

3.  p38γ and p38δ Are Involved in T Lymphocyte Development.

Authors:  Ana Risco; Miguel A Martin-Serrano; Domingo F Barber; Ana Cuenda
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

4.  Adenine Nucleotides Attenuate Murine T Cell Activation Induced by Concanavalin A or T Cell Receptor Stimulation.

Authors:  Yuria Shinohara; Mitsutoshi Tsukimoto
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.